Oncternal Therapeutics Announces Appointment of Chase Leavitt as General Counsel

Ads

You May Also Like

CytomX Therapeutics to Announce First Quarter 2018 Financial Results

SOUTH SAN FRANCISCO, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), ...